Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH)

Malaysia flag Malaysia · Delayed Price · Currency is MYR
2.080
-0.010 (-0.48%)
At close: Mar 5, 2026
-5.45%
Market Cap 295.04M
Revenue (ttm) 365.12M
Net Income (ttm) 25.03M
Shares Out 141.84M
EPS (ttm) 0.18
PE Ratio 11.78
Forward PE n/a
Dividend 0.08 (3.85%)
Ex-Dividend Date Dec 12, 2025
Volume 13,000
Average Volume 29,595
Open 2.090
Previous Close 2.090
Day's Range 2.080 - 2.090
52-Week Range 1.980 - 2.330
Beta 0.00
RSI 45.21
Earnings Date Feb 27, 2026

About KLSE:YSPSAH

Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices. It also m... [Read more]

Industry Pharmaceutical Preparations
Founded 1987
Employees 1,381
Stock Exchange Bursa Malaysia
Ticker Symbol YSPSAH
Full Company Profile

Financial Performance

In 2025, KLSE:YSPSAH's revenue was 365.12 million, a decrease of -0.96% compared to the previous year's 368.66 million. Earnings were 25.03 million, a decrease of -6.21%.

Financial Statements

News

There is no news available yet.